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FGFR1 Is Required for the Development
of the Auditory Sensory Epithelium
and the morphogenetic mechanisms, which direct the
precursor cells to their correct position (i.e., the future
OC), are poorly understood. No fate mapping studies of
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of the different OC cell types are mostly based on histo-2 Department of Otolaryngology
00014 University of Helsinki logical analyses. Also the promitotic signals responsible
for the expansion of the OC precursor cell pool areFinland
3 Department of Biological Sciences largely unknown. In addition to the developing cochlea,
it is possible that cells possessing stem/precursor cellStanford University
Stanford, California 94305 characteristics also exist in the mature hearing organ.
Knowledge of the cell lineage and precursor cell regula-
tion during development might be useful for the identifi-
cation of these cells in the adult cochlea and perhapsSummary
even for their mitogenic reactivation and therapeutic HC
regeneration.The mammalian auditory sensory epithelium, the or-
gan of Corti, comprises the hair cells and supporting Polypeptide growth factors, such as fibroblast growth
factor 2 (FGF2) and epidermal growth factor, stimulatecells that are pivotal for hearing function. The origin
and development of their precursors are poorly under- proliferation of neuronal precursor cells isolated from
different regions of the developing central nervous sys-stood. Here we show that loss-of-function mutations
in mouse fibroblast growth factor receptor 1 (Fgfr1) tem (for a review, see Gage, 2000). Several members of
the FGF family are expressed in the developing innercause a dose-dependent disruption of the organ of
Corti. Full inactivation of Fgfr1 in the inner ear epithe- ear, where FGF signaling has been implicated in induc-
tion and morphogenesis of the otic vesicle (Mansour etlium by Foxg1-Cre-mediated deletion leads to an 85%
reduction in the number of auditory hair cells. The al., 1993; Ladher et al., 2000; Pirvola et al., 2000; Vendrell
et al., 2000; Phillips et al., 2001) as well as cytodifferenti-primary cause appears to be reduced precursor cell
proliferation in the early cochlear duct. Thus, during ation within the OC (Colvin et al., 1996). We show here
by partial loss-of-function and otic epithelium-specificdevelopment, FGFR1 is required for the generation of
the precursor pool, which gives rise to the auditory null mutations that signaling by one of the FGF recep-
tors, FGFR1, is essential for the formation of the OC.sensory epithelium. Our data also suggest that FGFR1
might have a distinct later role in intercellular signaling Our results suggest that auditory HCs and supporting
cells are derived from a common precursor cell poolwithin the differentiating auditory sensory epithelium.
located in the ventromedial wall of cochlear duct and
reveal an essential molecular mechanism that stimulatesIntroduction
proliferation of these precursors of the OC.
The mammalian auditory sensory epithelium, the organ
of Corti (OC), is a cellular mosaic comprising the inner Results and Discussion
and outer hair cells (IHCs and OHCs) together with two
types of supporting cells, the pillar and Deiter’s cells. We have here analyzed the role of one of the FGF recep-
Retroviral marking studies have suggested that hair cells tors, FGFR1, in the developing inner ear. We first studied
(HCs) and supporting cells of the avian hearing organ Fgfr1 mRNA expression by in situ hybridization (Figure
share common precursors (Fekete et al., 1998). Recent 1). At embryonic day 9.5 (E9.5), Fgfr1 was expressed at
findings have shown that cell-cell communication within very low or undetectable levels in the otocyst (Figure
the presumptive OC has an instructive role in cell fate 1B). Fgfr1 expression was first detected at E10.5 in the
specification and differentiation. These processes criti- ventromedial wall of the otocyst (Figure 1A). At E11.5,
cally depend on the proneural gene Math1, encoding a at the initial stages of cochlear duct outgrowth, Fgfr1
basic helix-loop-helix transcription factor, and on the expression extended from this ventromedial domain into
components of the Notch signaling pathway (Berming- the ventral wall of the nascent cochlear duct (Figure 1C).
ham et al., 1999; Eddison et al., 2000). During the next few days, expression levels increased
Before cellular differentiation, additional mechanisms in the cochlear ventral wall, which comprises the primor-
must generate the precursor cell pool that gives rise dial auditory sensory epithelium (Lim and Anniko, 1985).
to the OC. Thymidine incorporation experiments have At E16.5, Fgfr1 was detected in the medial, thickened
shown that, in the mouse cochlea, the OC precursor region of the cochlear ventral wall, termed the greater
cells enter terminal mitoses between E12 and E15 (Ru- epithelial ridge (GER), and together with Fgfr3, in differ-
ben, 1967). p27Kip1, a cyclin-dependent kinase inhibitor, entiating OHCs and supporting cells of the more laterally
has been shown to promote the withdrawal of OC pre- located OC (Figures 1A, 1D, and 1E) (Peters et al., 1993).
cursors from the cell cycle (Chen and Segil, 1999; Lo- Concomittant to cellular maturation, Fgfr1 expression
wenheim et al., 1999). However, their origin, growth, was rapidly downregulated in the cochlear duct. In addi-
tion to the otic epithelium, the mesenchyme showed
high numbers of Fgfr1 transcripts throughout develop-4 Correspondence: ulla.pirvola@helsinki.fi
Figure 1. Fgfr1 Expression in the Embryonic Inner Ear, Description of the Mutant Fgfr1 Alleles Used in the Present Study, and the Pattern of
Foxg1-Cre-Mediated Recombination
(A) The early otocyst at E10 (a). The cochlear duct starts to grow out from the ventral wall of the otocyst between E11 and E12. The duct is
extending at E13 (b) and it spirals to contain 13⁄4 turns at E18.5 (c). At late embryogenesis, the differentiating organ of Corti comprises IHCs
and OHCs and two types of supporting cells, termed the Deiter’s and pillar cells (d). Red dots schematically depict Fgfr1 expression in the
otic epithelium.
(B) At E9.5, Fgfr1 is expressed in the mesenchyme and hindbrain. No detectable expression is seen in the otocyst.
(C) At E11.5, in addition to the mesenchyme, Fgfr1 is expressed in the ventromedial wall of the otocyst (arrow) and weakly in the ventral wall
of the nascent cochlear duct.
(D and E) At E16.5, Fgfr1 (D) and Fgfr3 (E) are expressed in the differentiating organ of Corti (arrows) and in the mesenchyme. Fgfr1 is also
detected in the greater epithelial ridge. The short arrows mark the region of OHCs, long arrows the IHC. Pillar cells, which express Fgfr3 but
not Fgfr1, are marked by arrowheads.
(F) Structures of the FGFR1 protein and the wild-type Fgfr1 locus are shown at the top. In Fgfr1n7 and Fgfr1n15YF alleles, a neo cassette flanked
by loxP sites is inserted into introns 7 and 15, respectively. Fgfr1flox allele contains loxP sites in introns 7 and 15. Cre-mediated recombination
results in excision of the DNA flanked by the loxP sites generating a null allele, Fgfr1flox.
(G) Otocysts of the E11.5 Fgfr1flox/flox;Foxg1-Cre/ mice do not show Fgfr1 expression, as detected by a probe containing exon sequences
between the loxP sites. The arrow marks the ventromedial wall. Fgfr1 expression is maintained in the mesenchyme.
(H) Alkaline phosphatase staining of E13.5 Foxg1-Cre/;Z/AP/ inner ears shows Cre-mediated recombination exclusively in the otic epithelium
and the cochleovestibular ganglion. Abbreviations: ot, otocyst; cd, cochlear duct; me, mesenchyme; ve, vestibulum; sv, spiral vessel; IHC,
inner hair cell, OHC, outer hair cell; Ps, pillar cells; Ds, Deiter’s cells; ger, greater epithelial ridge; cg, cochlear ganglion; cvg, cochleovestibular
ganglion. Scale bar in (H), 70 m for (B), (D), and (E); 140 m for (C) and (G); 200 m for (H).
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Figure 2. Disruption of the Organ of Corti, but Unaltered Vestibular Sensory Epithelium of FGFR1 Loss-Of-Function Mutant Mice
Phalloidin-stained surface specimens of the cochlea (A–D), semithin transverse sections through the organ of Corti (E–G), and calretinin-
immunostained sections through the sacculus (H and I) at P0. (A) A control cochlea shows one continuous row of inner hair cell (IHCs) and
three rows of outer hair cells (OHCs). The dotted line marks the orientation of sectioning in (E). (B–D) In Fgfr1n7/n7 (B) and Fgfr1n15YF/15YF (C)
hypomorphs and in Fgfr1flox/flox;Foxg1-Cre/ mutants (D), the organ of Corti is disrupted in a dose-dependent fashion. The sensory patches
of Fgfr1n15YF/n15YF and Fgfr1flox/flox;Foxg1-Cre/ mutants are of variable size, and they frequently show doublet IHCs and an accumulation of
disorientated IHCs at the edges. Open arrows in (C) point to the sensory patches, and the asterisk marks a gap between the patches. Dotted
lines in (D) mark the orientation of sectioning in (F) and (G). (E–G) In contrast to normal cochleas (E), sections through the cochleas of
Fgfr1flox/flox;Foxg1-Cre/ mutants show IHCs and supporting cells without OHCs. Hair cells are identified by their cylindrical shape and by
their stereocilia facing the lumen, and supporting cells by their dark cytoplasm (F). Several sections without any signs of differentiation of the
organ of Corti are found in these cochleas (G). These sections represent the gaps between the sensory patches seen in surface specimens.
(H and I) As detected by calretinin staining, the sacculus shows similar numbers of hair cells in control and Fgfr1flox/flox;Foxg1-Cre/ mice.
Abbreviations: IHC, inner hair cell; OHC, outer hair cell; GER, greater epithelial ridge; sv, spiral vessel; Ps, pillar cell; Ds, Deiter’s cells. Scale
bar in (I), 110 m for (A)–(D); 25 m for (E)–(G); 120 m for (H) and (I).
ment (Figures 1B and 1C). Alternative splicing generates were found to be coexpressed in the otic epithelium
throughout development (data not shown). Taken to-two Fgfr1 isoforms, the IIIb and IIIc forms (Werner et al.,
1992). By using isoform-specific probes, Fgfr1 variants gether, Fgfr1 is expressed at several stages of the devel-
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Figure 3. Cell Fate Specification and Differentiation in the Organ of Corti of FGFR1 Loss-Of-Function Mutant Mice
Calbindin immunohistochemistry and Math1 in situ hybridization in transverse sections at E18.5.
(A) Calbindin staining reveals the normal pattern of one inner hair cell (IHC) (long arrow) and three outer hair cells (OHCs) (short arrows).
(B and C) Fgfr1flox/flox;Foxg1-Cre/ mutants show only low numbers of calbindin-positive hair cells (IHCs) (B). Most sections are devoid of hair
cells, and the greater epithelial ridge (GER) is thin (C).
(D and E) Sections through the cochleas of Fgfr1n15YF/15YF mice show variable numbers of OHCs and frequently doublet IHCs. Many hair cells
appear shorter (D) than those in controls. Sections without any calbindin-stained hair cells are also found (E).
(F) Math1 is expressed in hair cells of control cochleas.
(G and H) Cochleas of Fgfr1n15YF/15YF mutants comprise regions with Math1-expressing hair cells (G) and regions without any signs of hair cell
specification (H). Scale bar in (H), 30 m for (A)–(E); 50 m for (F)–(H).
oping inner ear, especially in regions contributing to the genesis appeared largely normal in both hypomorphs.
These data point to a specific role of Fgfr1 in the genera-formation of the OC.
To study the function of FGFR1 in the developing tion of the cells of the auditory sensory epithelium.
To gain more insight into the quantitative require-inner ear, we analyzed mice carrying loss-of-function
mutations in the Fgfr1 gene. Fgfr1 null mutants die dur- ments of Fgfr1 in the otic epithelium, we completely
inactivated Fgfr1 in this compartment. We took advan-ing gastrulation (Deng et al., 1994; Yamaguchi et al.,
1994). Therefore, we first studied the cochlear pheno- tage of a mouse line carrying a conditional Fgfr1 allele,
Fgfr1flox (Figure 1F), which can be inactivated by Cretype of mice homozygous for the hypomorphic Fgfr1
alleles, Fgfr1n7 and Fgfr1n15YF, which cause 80% and 90% recombinase, and of the Foxg1-Cre mouse line in which
the Cre coding sequence is targeted to the Foxg1 locusreductions in the levels of full-length Fgfr1 transcripts,
respectively (Figure 1F) (Partanen et al., 1998). Both (He´bert and McConnell, 2000). Foxg1 is expressed in
the otic vesicle (He´bert and McConnell, 2000), and thusFgfr1n7/n7 and Fgfr1n15YF/n15YF hypomorphs die within 24 hr
after birth. Whole-mount cochlear surface specimens the Foxg1-Cre mice offered a possible means of region-
ally inactivating Fgfr1 in the epithelium of the developingwere prepared at birth and stained with phalloidin, which
reveals the apical, mechanosensory region of HCs as inner ear. We therefore generated mice carrying one
conditional (Fgfr1flox) and one null (Fgfr1flox) allele of Fgfr1well as the apical borders of the supporting cells located
between HCs. The normal pattern of one row of IHCs as well as a Foxg1-Cre allele (Figure 1F). To verify Fgfr1
inactivation by the Foxg1-Cre allele, we analyzed spatio-and three rows of OHCs that extends through the co-
chlear duct (Figure 2A) was disrupted in both hypo- temporal expression of Fgfr1 in Fgfr1flox/flox;Foxg1-Cre/
embryos using a probe specific for the region deletedmorphs. In the milder Fgfr1n7/n7 mice, the third OHC row
was missing throughout the length of the cochlear duct by Cre-mediated recombination. As analyzed at E10.5,
E11.5, E13.5, and E16.5, the otocyst, but not the sur-(Figure 2B). In the stronger Fgfr1n15YF/n15YF mice, similar
perturbations were seen in the lower half of the cochleas. rounding mesenchyme, of the conditionally inactivated
embryos was devoid of Fgfr1 expression (Figure 1G).In contrast, the sensory epithelium of the upper half of
their cochleas was arranged in patches (open arrows in These results indicate that Foxg1-Cre-mediated recom-
bination is restricted to the otocyst and that it occursFigure 2C) rather than as continuous rows as seen in
controls. The gaps (asterisk in Figure 2C) between the at the initial stages of Fgfr1 expression. We further con-
firmed tissue specificity of Cre-mediated recombinationpatches showed no signs of differentiation of HCs or
supporting cells. In contrast to these disturbances in by crossing Foxg1-Cre mice with Z/AP reporter mice,
which express placental alkaline phosphatase upon re-cellular development within the OC, cochlear morpho-
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Figure 4. Impaired Production of Precursor
Cells of the Organ of Corti in Fgfr1flox/flox;
Foxg1-Cre Mice
Expression of Fgfs at the stage when these
precursors are generated.
(A and B) At E11.5, otocysts of both control (A)
and mutant (B) embryos show intense BrdU
labeling. Arrows mark the ventromedial wall.
(C and D) At E13.5, control mice show high
numbers of BrdU-labeled cells in the greater
epithelial ridge (arrow) (C). In the greater epi-
thelial ridge (arrow) of mutants, numbers of
BrdU-positive cells are markedly reduced (D).
(E and F) The cochlear duct of E14.5 control
mice shows Nt-3 expression in the greater
epithelial ridge (large arrow) and, more later-
ally, at the site of the presumptive organ of
Corti (small arrow) (E). Nt-3 expression is
markedly downregulated in the thin ventral
wall of the cochlear duct of mutants (F).
(G) At E13.5, Fgf8 is expressed in the otic
epithelium, including the junction of the out-
growing cochlear duct, and in delaminating
neuroblasts (arrowhead and open arrow). The
thick arrow marks the ventromedial wall of
the otocyst.
(H) At E13.5, similar to Fgf8, Fgf10 is ex-
pressed in the otocyst, including the junction
of the cochlear duct, and in delaminating neu-
roblasts (arrowhead and open arrow). Addi-
tionally, Fgf10 is found in the greater epithelial
ridge and the cochleovestibular ganglion. Ab-
breviations: ot, otocyst; cd, cochlear duct; cvg,
cochleovestibular ganglion. Scale bar in (H),
160 m for (A) and (B); 70 m for (C)–(F); 200
m for (G) and (H).
combination (Lobe et al., 1999). Consistent with earlier phalloidin-stained cochlear surface specimens pre-
pared from these mutants showed a severely disrupteddata on E8.5–E11.5 embryos (He´bert and McConnell,
2000), the E13.5 double transgenic embryos (Foxg1- OC. As compared to Fgfr1n15YF/n15YF hypomorphs, the sen-
sory patches were reduced in size, and they mainlyCre/;Z/AP/) showed alkaline phosphatase staining
in distinct, ectoderm-derived head structures, including comprised IHCs and supporting cells (Figure 2D). Similar
to the hypomorphs, the upper half of cochleas ofthe otocyst. Cre-mediated recombination was seen
throughout the otic epithelium, including the nascent Fgfr1flox/flox;Foxg1-Cre/ mice was more severely per-
turbed than the lower half. Only very low numbers ofcochlear duct, and in the neurons of the cochleovestibu-
lar ganglion, which are derived from the otic epithelium OHCs were formed, and these were located in the lower
part of the cochleas. At postnatal day 0 (P0), the total(Figure 1H). The surrounding mesenchyme was nega-
tive. Thus, although Fgfr1 is expressed both in the epi- number of differentiating HCs averaged 2212 150 (n
6 cochleas) in controls and 302  54 (n  9 cochleas)thelium and mesenchyme of the developing cochlea,
our strategy provided a tool to study the role of Fgfr1 in Fgfr1flox/flox;Foxg1-Cre/ mutants (the apical region
of the cochleas comprising immature HCs was not in-specifically in the epithelium, including HCs and sup-
porting cells of the OC as well as their precursors. cluded in the counts). By counting differentiating OHCs
only, these values were 1702  112 (n  6) and 37 Similar to the hypomorphs, Fgfr1flox/flox;Foxg1-Cre/
mutants died within 24 hr after birth. Around birth, 12 (n  9), respectively. A comparable phenotype was
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seen in Fgfr1flox/flox;Foxg1-Cre/ mice (data not shown).
Thus, Fgfr1 regulates the numbers of HCs and support-
ing cells formed in a dose-dependent fashion, and inter-
estingly, the requirement for Fgfr1 varies along the
length of the cochlear duct. In contrast to the OC, the
morphology of the vestibular organs of the inner ear
appeared normal in Fgfr1flox/flox;Foxg1-Cre/ mice at
birth. The presence of a normal complement of vestibu-
lar HCs was verified by using calretinin as a marker for
these cells (Figures 2H and 2I).
We examined whether defects in cellular death, differ-
entiation, fate specification, or proliferation account for
the altered phenotype. In transverse sections at birth,
the global morphology of the cochleas of Fgfr1flox/flox;
Foxg1-Cre/ mice was largely normal, except that fre-
quently the cochleas were slightly shorter than in con-
trols (data not shown). Between E13.5 and birth, mor-
phological analysis and TUNEL staining (Figures 2E–2G,
and data not shown) showed no differences in the extent
of cell death in the ventral wall of the cochlear duct
Figure 5. Clonal Analysis in the Cochleas of Hypomorphic Fgfr1
where precursors and, later, differentiating cells of the Mutants
OC are located. Around birth, semithin sections through
Whole mounts of E18.5 Fgfr1n15YF/n15YF;D4/XEgfp/ embryos were
the control cochleas showed the characteristic pattern double labeled with phalloidin (red) and an EGFP antibody (green).
of one IHC, three OHCs, and the underlying supporting Cells of the sensory patches (open arrows) are not clonally related,
as evidenced by heterogenous EGFP staining. Scale bar, 50 m.cells (Figure 2E). In contrast, in the sensory patches of
Fgfr1flox/flox;Foxg1-Cre/ mutants, IHCs were accompa-
nied by supporting cells, but most sections were devoid
and E11.5. This was relevant since, as described above,of OHCs (Figure 2F). Sections through the gaps between
Fgfr1 is expressed at these stages in the ventromedialthe sensory patches showed no signs of cellular differ-
wall of the otocyst. We could not see differences be-entiation typical to the OC (Figure 2G).
tween otocysts of mutants and controls in cellular prolif-By using molecular markers, we examined the possi-
eration (Figures 4A and 4B), cellular death, or in thebility that precursors of the OC adopt their fates as HCs
expression of genes, such as neurotrophin-3 (Nt-3),or supporting cells, but their morphological differentia-
Fgf10, Fgf8, Pax2, Gbx2, Notch1, Serrate1, Delta 1, andtion is blocked. Calbindin marks differentiating HCs.
Lunatic Fringe, which mark the different domains of the
At birth, calbindin was expressed in HCs of control
otic epithelium (data not shown). Additionally, at E12,
cochleas (Figure 3A). Fgfr1n15YF/n15YF and especially
no morphological differences were seen in the initiation
Fgfr1flox/flox;Foxg1-Cre/ mutants showed a marked re-
of cochlear duct outgrowth from the otocyst. This stands
duction in the numbers of calbindin-positive HCs (Fig- in contrast to the role of Fgfr2(IIIb), which is essential
ures 3B–3E). Math1 is involved in HC specification (Ber- for the budding morphogenesis of the inner ear (Pirvola
mingham et al., 1999). As analyzed at E16.5 and at birth, et al., 2000). As described above, the vestibular sensory
Math1 was expressed in HCs of control mice (Figure 3F). epithelia of Fgfr1flox/flox;Foxg1-Cre/ animals showed no
In the cochleas of Fgfr1n15YF/n15YF mice, Math1 transcripts abnormalities (Figures 2H and 2I). As the cochlear and
were found in the sensory patches, but not in the in- part of the vestibular sensory epithelia are thought to
tervening gap regions (Figures 3G and 3H). In these derive from the same region of the otocyst, this result
hypomorphs, similar regional distribution was observed further supports our conclusion that patterning of the
for the Notch ligands Delta1 (HCs; Eddison et al., 2000) early otocyst is not altered in Fgfr1 mutants.
and Serrate1 (supporting cells; Eddison et al., 2000) The possibility still remained that the generation of the
(data not shown). In the cochleas of Fgfr1flox/flox;Foxg1- pool of precursor cells giving rise to the OC is affected by
Cre/ mice, the specification markers showed a very Fgfr1 mutations. In the mouse, these precursors exit
restricted expression (data not shown). These data indi- the cell cycle between E12 and E15 (Ruben, 1967). As
cate first, that there are no molecular signs of HC specifi- assessed by bromodeoxyuridine (BrdU) incorporation,
cation or differentiation in the gap regions and second, Fgfr1flox/flox;Foxg1-Cre/ mice showed a reduction in
that the remaining HCs in the sensory patches undergo proliferation rate in the ventral wall of the cochlear duct.
normal differentiation. Together with the fact that the Attenuation of proliferation was evident already at E12,
altered phenotypes were evident already between E15.5 but became very prominent between E13.5 and E15.5
and E16.5 (data not shown), at the onset of cellular (Figures 4C and 4D). Quantitative analysis performed
differentiation, these data suggest that Fgfr1 mutations between E13.5 and E14.5 revealed highly significant dif-
act on developmental events occurring before specifica- ferences (p  0.005) between mutants (7.7  2.4 BrdU-
tion and differentiation processes. labeled cells in the GER per section, n  12 cochleas)
To determine whether early patterning defects could and control littermates (57.4  13.5, n  12). At E14.5
explain the altered cochlear phenotype, we examined and thereafter, impaired proliferation resulted in a thin-
ner GER and a marked reduction in the level of Nt-3,otocysts of Fgfr1flox/flox;Foxg1-Cre/ mutants at E10.5
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Figure 6. Altered Cytoarchitecture of the Or-
gan of Corti of Fgfr1flox/flox;Foxg1-Cre/ Mu-
tant Mice at E18.5
Expression of Fgfs in the organ of Corti at
E16.5.
(A and B) Phalloidin-stained surface speci-
mens of the organ of Corti show the normal
pattern of four hair cell rows and intervening
apical processes of supporting cells (A). In
mutants, this pattern is replaced by sensory
patches (open arrows) with no or only a few
outer hair cells (OHCs). In addition to the
patches, small islands of sensory epithelium
(arrowheads), invariably including at least a
few hair cells, are found outside the normal
area of the organ of Corti (B).
(C and D) As compared to controls (C), p75
labeling shows clusters of pillar cells (Ps) in
the sensory patches of mutant mice (D). In
addition to pillar cells, p75 is expressed in
the cochlear nerve (CN) and Claudius cells
(CL). Red arrows point to hair cells.
(E) In the differentiating organ of Corti, Fgf8
is expressed exclusively in the inner hair cells
(IHCs).
(F) At the same stage, Fgf10 is found in the
greater epithelial ridge (ger), especially in the
region of IHCs.
(G) Proposed roles of FGFR1 during inner ear
development. In the otocyst, FGFR1 stimu-
lates proliferation of the precursors of the or-
gan of Corti. During late embryogenesis,
FGFR1—together with FGFR3—is suggested
to promote cytodifferentiation within the or-
gan of Corti. Scale bar in (F), 40 m for (A)
and (B); 60 m for (C) and (D); 50 m for (E)
and (F).
which marks the presumptive inner ear sensory epithelia found in the neurons of the cochleovestibular ganglion
and, similar to Fgfr1, in the GER of the cochlear duct(Figures 4E and 4F) (Pirvola et al., 1992). Notably, no
differences in proliferation rate between mutants and (Figure 4H). Available data on neurogenin1 and neuro-
trophin knockout mice, in which the cochleovestibularcontrols were seen in the dorsal, nonsensory wall of
the cochlear duct (Figures 4C and 4D). Thus, our data ganglion is not formed or it degenerates soon after com-
paction, indicate that the neurons or migrating neuro-indicate that FGFR1 signaling stimulates precursor cell
proliferation specifically in the sensory compartment of blasts do not have a major impact on HC development
(Fritzsch et al., 1997; Ma et al., 2000). Therefore, stimula-the cochlea, and impaired proliferation is likely to ac-
count for the absence of large numbers of HCs and tion of proliferation of the OC’s progenitors is likely to
depend on interaction between FGFs and FGFR1 withinsupporting cells, as seen in Fgfr1mutants at birth.
We next examined the nature and source of FGF li- the otic epithelium. Ligand binding properties of FGFRs
are regulated by alternative splicing. As describedgands that might interact with FGFR1 to regulate the
size of the progenitor pool of the OC. Of the several above, Fgfr1(IIIb) and Fgfr1(IIIc) isoforms, differing in
their extracellular region (Werner et al., 1992), are coex-Fgfs analyzed between E11.5 and E14.5, Fgf8 and Fgf10
were found to be expressed in a spatiotemporal pattern, pressed in the otic epithelium. Interestingly, FGF10 has
been reported to bind to FGFR1(IIIb), but not to FGFR1which appears relevant for our studies. Fgf8 and Fgf10
are expressed in the ventral part of the otocyst and in (IIIc) (Igarashi et al., 1998; Lu et al., 1999). We therefore
analyzed the inner ear phenotype of Fgfr1(IIIb) mutantthe delaminating cochleovestibular neuroblasts (Figures
4G and 4H) (Pirvola et al., 2000). Additionally, Fgf10 was mice, which survive until adulthood (Fgfr1IIIBL/IIIBL) (Parta-
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nen et al., 1998). Adult Fgfr1IIIBL/IIIBL mice showed normal signaling pathway, which stimulates proliferation of pre-
cochlear morphology and hearing function as measured cursor cells of the OC (Figure 6G). During development
by auditory brainstem responses (six mutant and six of several cell populations, including neurons of the fore-
control littermates analyzed; data not shown). Together, brain and olfactory bulb, a cell lineage progression from
these data indicate that FGF10/FGFR1(IIIb) interaction stem cells to rapidly dividing progenitors and further to
alone is insufficient for the generation of the cochlear mature quiescent cells has been proposed (Martens et
sensory epithelium and argue for the importance of al., 2000; Doetsch et al., 2002). Our data suggest that
FGFs acting through FGFR1(IIIc) to stimulate precursor actively proliferating OC precursors reside in the GER
cell proliferation. of the cochlear duct. They may represent transit-ampli-
As seen at birth, the reduced numbers of HCs and fying cells that proliferate rapidly and symmetrically and
supporting cells found in Fgfr1flox/flox;Foxg1-Cre/ and gradually move to their final destination, the OC proper.
Fgfr1n15YF/n15YF mutants were arranged in patches rather In this location, the precursors exit the cell cycle and
than being distributed in a scattered manner. A possible local cues direct their differentiation into HCs or sup-
explanation for the spatial clustering of these cells is porting cells. Interestingly, the FGF-responsive neural
that the cells in the same patch are derived from a precursors of the embryonic forebrain are also thought
common precursor cell. To test this hypothesis, we used to undergo a phase of rapid symmetric cellular divisions
a mouse line in which enhanced green fluorescent pro- to increase their population size (Martens et al., 2000).
tein (EGFP) is integrated into the X chromosome (D4/ Furthermore, FGF signaling through FGFR1 has been
XEgfp transgenic mice; Hadjantonakis et al., 1998). Ran- suggested to stimulate proliferation of neural precursor
dom X inactivation, which occurs between E5.5 and E8.5 cells (Tropepe et al., 1999; Vaccarino et al., 1999). Thus,
in the mouse (Tan et al., 1993), yields mosaic females the cellular and molecular mechanisms regulating the
in which 50% of cells are EGFP positive. We then gener- precursor cell pools in the developing OC and central
ated Fgfr1n15YF/n15YF hypomorphs that showed EGFP mo- nervous system may be related.
saicism (Fgfr1n15YF/n15YF;D4/XEgfp/). If cells in a sensory Unlike in the bird’s hearing organ, the adult mamma-
patch are clonally related, the patches should be uni- lian cochlea is thought to lack regenerative capacity.
formly either EGFP positive or negative. Doublestaining Future studies are needed to investigate whether pre-
with phalloidin and EGFP antibodies revealed that the cursors, perhaps genuine stem cells, exist in the mature
sensory patches are heterogenous for EGFP expression cochlea, similarly as recently shown in the retina (Tro-
(Figure 5). Thus, the patchy arrangement of the OC pepe et al., 2000) and whether the downregulation of
seems to be caused by mechanisms other than clonality, FGFR1 contributes to their quiescence. The present re-
perhaps by preferential adhesion of the precursors of sults might help to design strategies for activation and/
HCs and supporting cells with each other. or expansion of the precursor cell pool that could give
Of the different cell types of the OC, the numbers of rise to new HCs, even in the adult hearing organ.
OHCs were most severely affected in Fgfr1 mutants
(Figures 6A and 6B). By using morphological criteria
Experimental Proceduresand p75 as a molecular marker (von Bartheld et al.,
1991), clusters of pillar cells, one type of supporting Mutant Mice
cell of the OC, were seen in the sensory patches of The alleles Fgfr1n7 and Fgfr1n15YF as well as the generation of the
Fgfr1flox/flox;Foxg1-Cre/ mice at birth (Figures 2F and Fgfr1IIIBL/IIIBL mutant mice have been described by Partanen et al.
(1998). The generation and characterization of the Fgfr1flox and6A–6D). These results suggest that the remaining pre-
Fgfr1flox alleles will be described in detail elsewhere. Briefly, thecursors of the OC preferentially differentiate into IHCs
Fgfr1flox allele contains two loxP sites inserted into introns flankingand pillar cells. Thus, in addition to stimulating precursor
the exons 8–15 of the Fgfr1 gene (Figure 1F). Mice homozygous for
cell proliferation in the nascent cochlear duct, FGFR1 the Fgfr1flox allele are phenotypically normal. Cre-mediated recombi-
may have a distinct later function in the differentiating nation of the Fgfr1flox allele creates the Fgfr1flox allele. Mice heterozy-
OC to promote especially OHC development. In line with gous for this allele are normal, whereas homozygotes show a pheno-
this suggestion, Fgfr1 expression was detected in the type similar to Fgfr1 null mutants described earlier (Yamaguchi et
al., 1994). The Foxg1-Cre mice have been described by He´bert andearly-differentiating OHCs (Figures 1A and 1D). Fgfr3,
McConnell (2000), and the D4/XEgfp mice carrying a X-chromo-but not Fgfr1, is expressed the pillar cells (Figures 1A,
somal Egfp transgene by Hadjantonakis et al. (1998). All the analyses1D, and 1E), these results being consistent with the
were done in outbred genetic backround (ICR).
phenotype of Fgfr3 knockout mice in which pillar cells
fail to differentiate (Colvin et al., 1996). Thus, these two
Cochlear Whole MountsFGFRs might have at least to some extent complemen-
Cochlear ducts were dissected from E18.5 and P0 mice and fixedtary functions during the OC’s differentiation. IHCs,
in 4% paraformaldehyde (PFA) in phosphate buffered saline (PBS)
which are the first cell type to start to differentiate within (pH 7.2) overnight at 4C. The tectorial membrane was removed.
the OC, express Fgf8 throughout life (Figure 6E, and Whole-mount specimens were incubated with rhodamine-phalloidin
data not shown). In addition, Fgf10 (Figure 6F) and Fgf3 (Molecular Probes) and mounted in Vectashield (Vector Labora-
(data not shown) are expressed in the region of differ- tories, Burlingame, CA) (n  12 control cochleas, n  20 Fgfr1flox/flox;
Foxg1-Cre/ cochleas, n 20 Fgfr1n15YF/n15YF cochleas, n 6 Fgfr1n7/n7entiating IHCs. Thus, we suggest that pioneering cells
cochleas). Cochleas of Fgfr1n15YF/n15YF;D4/XEgfp/mice (n 12) wereof the OC, the IHCs, stimulate differentiation of their
double labeled with rhodamine-phalloidin and a polyclonal rabbitlater-emerging neighbors through FGF/FGFR signaling,
EGFP antibody (Molecular Probes, Eugene, OR), followed by incuba-
in a similar fashion as receptor tyrosine kinase signaling tion with Alexa 488-coupled secondary antibody (Molecular Probes).
has been shown to regulate development of the sense Images were captured using a Zeiss Axiovert 100/135 epifluorescent
organs of Drosophila (Freeman, 1997). microscope (Go¨ttingen, Germany) connected to a Bio-Rad MRC-
1024 confocal laser scanning system (Hemel Hemstead, UK).In conclusion, this work has elucidated an essential
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Histology Deng, C.X., Wynshaw-Boris, A., Shen, M.M., Daugherty, C., Ornitz,
D.M., and Leder, P. (1994). Murine FGFR-1 is required for earlyEmbryos between E8.5 and E16.5 and inner ears dissected at E18.5
and P0 were fixed in PFA as described above. Paraffin-embedded postimplantation growth and axial organization. Genes Dev. 8, 3045–
3057.sections were cut at 5 m in transverse plane. Sections were incu-
bated with the rabbit polyclonal calbindin and calretinin antibodies Doetsch, F., Verdugo, J.M., Caille, I., Alvarez-Buylla, A., Chao, M.V.,
(Swant, Bellinzona, Switzerland) and the polyclonal p75 antibody (a and Casaccia-Bonnefil, P. (2002). Lack of the cell-cycle inhibitor
kind gift from Dr. M. Chao). Detection was done by the peroxidase p27Kip1 results in selective increase of transit-amplifying cells for
ABC kit (Vector Laboratories) and 33diaminobenzidine. Sections adult neurogenesis. J. Neurosci. 22, 2255–2264.
were counterstained with methyl green.
Eddison, M., Le Roux, I., and Lewis, J. (2000). Notch signaling in
Pregnant females were injected intraperitoneally with BrdU (Amer-
the development of the inner ear: lessons from Drosophila. Proc.
sham-Pharmacia, Buckinghamshire, UK) and killed 2 hr after injec-
Natl. Acad. Sci. USA 97, 11692–11699.
tion. PFA-fixed paraffin sections were denaturated with 2 N HCl,
Fekete, D.M., Muthukumar, S., and Karagogeos, D. (1998). Hair cellstrypsinized, and incubated with a mouse monoclonal BrdU antibody
and supporting cells share a common progenitor in the avian inner(Amersham-Pharmacia). Detection and counterstaining were done
ear. J. Neurosci. 18, 7811–7821.as above. BrdU-labeled cells were counted from the GER of E13.5
Freeman, M. (1997). Cell determination strategies in the Drosophilaand E14.5 cochleas. Eight mutant and 8 control embryos (16 co-
eye. Development 124, 261–270.chleas per group, 4 to 5 sections from each cochlea) were included
in the analysis. Values presented are the mean  SD. Significance Fritzsch, B., Farinas, I., and Reichardt, L.F. (1997). Lack of neuro-
was determined using Student’s t test. trophin 3 causes losses of both classes of spiral ganglion neurons in
Paraffin sections were used for in situ hybridization with 35S- the cochlea in a region-specific fashion. J. Neurosci. 17, 6213–6225.
labeled riboprobes, using a procedure described by Wilkinson and Gage, F.H. (2000). Mammalian neural stem cells. Science 287, 1433–
Green (1990). Pan-Fgfr1, Fgfr1(IIIb), Fgfr1(IIIc), Math1, Pax2, Gbx2, 1438.
Notch1, Delta1, Serrate1, Lunatic Fringe, Nt-3, Fgf10, and Fgf8
Hadjantonakis, A.K., Gertsenstein, M., Ikawa, M., Okabe, M., andprobes were used. For the analysis of Fgfr1 inactivation by Cre-
Nagy, A. (1998). Non-invasive sexing of preimplantation stage mam-mediated recombination, a probe containing exon sequences be-
malian embryos. Nat. Genet. 19, 220–222.tween the loxP sites was used. Three specimens or more of both
He´bert, J.M., and McConnell, S.K. (2000). Targeting of cre to themutants and controls at each stage were used for each antibody
Foxg1 (BF-1) locus mediates loxP recombination in the telencepha-and probe. An Olympus Provis microscope (Tokyo, Japan) and a
lon and other developing head structures. Dev. Biol. 222, 296–306.Photometrics SenSys CCD videocamera (Tucson, AZ) were used to
obtain digitized images. Igarashi, M., Finch, P.W., and Aaronson, S.A. (1998). Characteriza-
For alkaline phosphatase staining, E13.5 Foxg1-Cre/;Z/AP/ tion of recombinant human fibroblast growth factor (FGF)-10 reveals
(n  4) and control (n  2) embryos were fixed in 4% PFA for 3 hr functional similarities with keratinocyte growth factor (FGF-7). J.
and cut to 7 m thick cryostat sections. They were incubated in Biol. Chem. 273, 13230–13235.
PBS at 70C for 30 min to inactivate endogenous phosphatases, Ladher, R.K., Anakwe, K.U., Gurney, A.L., Schoenwolf, G.C., and
followed by incubation with BM purple (Roche, Mannheim, Germany) Francis-West, P.H. (2000). Identification of synergistic signals initiat-
for 4 hr at room temperature to detect alkaline phosphatase activity. ing inner ear development. Science 290, 1965–1967.
Kaiser’s Gelatine (Roche) was used for mounting. Control specimens
Lim, D.J., and Anniko, M. (1985). Developmental morphology of thedid not show any staining.
mouse inner ear. A scanning electron microscopic observation. ActaCochleas (n  5 controls, n  6 Fgfr1flox/flox;Foxg1-Cre/, n  6
Otolaryngol. Suppl. 422, 1–69.Fgfr1n15YF/n15YF) were dissected at birth and fixed in 2.5% glutaralde-
Lobe, C.G., Koop, K.E., Kreppner, W., Lomeli, H., Gertsenstein, M.,hyde in 0.1 M phosphate buffer (pH 7.2) overnight at 4C, postfixed
and Nagy, A. (1999). Z/AP, a double reporter for cre-mediated re-in 1% osmium tetroxide, and embedded in Epon. One micron thick
combination. Dev. Biol. 208, 281–292.plastic sections were cut in transverse plane and stained with tolu-
idine blue. Lowenheim, H., Furness, D.N., Kil, J., Zinn, C., Gultig, K., Fero, M.L.,
Frost, D., Gummer, A.W., Roberts, J.M., Rubel, E.W., et al. (1999).
Gene disruption of p27(Kip1) allows cell proliferation in the postnatalAcknowledgments
and adult organ of Corti. Proc. Natl. Acad. Sci. USA 96, 4084–4088.
We are grateful to M. von Numers and L. Xing-Qun for technical Lu, W., Luo, Y., Kan, M., and McKeehan, W.L. (1999). Fibroblast
assistance; N. Trokovic for help with the hypomorphic mouse lines; growth factor-10. A second candidate stromal to epithelial cell an-
A. Nagy for the Z/AP and D4/XEgfp mice; D. Henrique (components dromedin in prostate. J. Biol. Chem. 274, 12827–12834.
of the Notch signaling), J. Johnson (Math1), P. Gruss (Pax2), W. Ma, Q., Anderson, D.J., and Fritzsch, B. (2000). Neurogenin1 null
Wurst (Gbx2), B. Hogan (Fgf10), C. MacArthur (Fgf8), P. Lonai (pan- mutant ears develop fewer, morphologically normal hair cells in
Fgfr1), P. Kettunen (Fgfr1(IIIb) and Fgfr1(IIIc)), and M. Saarma (Nt-3) smaller sensory epithelia devoid of innervation. J. Assoc. Res. Otola-
for probes; M. Chao for the p75 antibody; and R. Romand and I. ryngol. 1, 129–143.
Thesleff for critically reading the manuscript. This work was sup-
Mansour, S.L., Goddard, J.M., and Capecchi, M.R. (1993). Miceported by Sigrid Juse´lius Foundation, the Academy of Finland, and
homozygous for a targeted disruption of the proto-oncogene int-2Biocentrum Helsinki.
have developmental defects in the tail and inner ear. Development
117, 13–28.Received: November 6, 2001
Martens, D.J., Tropepe, V., and van der Kooy, D. (2000). SeparateRevised: April 17, 2002
proliferation kinetics of fibroblast growth factor-responsive and epi-
dermal growth factor-responsive neural stem cells within the embry-References
onic forebrain germinal zone. J. Neurosci. 20, 1085–1095.
Bermingham, N.A., Hassan, B.A., Price, S.D., Vollrath, M.A., Ben- Partanen, J., Schwartz, L., and Rossant, J. (1998). Opposite pheno-
Arie, N., Eatock, R.A., Bellen, H.J., Lysakowski, A., and Zoghbi, H.Y. types of hypomorphic and Y766 phosphorylation site mutations re-
(1999). Math1: an essential gene for the generation of inner ear hair veal a function for Fgfr1 in anteroposterior patterning of mouse
cells. Science 284, 1837–1841. embryos. Genes Dev. 12, 2332–2344.
Chen, P., and Segil, N. (1999). P27Kip1 links cell proliferation to mor- Peters, K., Ornitz, D., Werner, S., and Williams, L. (1993). Unique
phogenesis in the developing organ of Corti. Development 126, expression of the GHG receptor 3 gene during mouse organogene-
1581–1590. sis. Dev. Biol. 155, 423–430.
Phillips, B.T., Bolding, K., and Riley, B.B. (2001). Zebrafish fgf3 andColvin, J.S., Bohne, B.A., Harding, G.W., McEwen, D.G., and Ornitz,
D.M. (1996). Skeletal overgrowth and deafness in mice lacking fibro- fgf8 encode redundant functions required for otic placode induction.
Dev. Biol. 235, 351–365.blast frowth factor receptor 3. Nat. Genet. 12, 390–397.
Neuron
680
Pirvola, U., Ylikoski, J., Palgi, J., Lehtonen, E., Arumae, U., and
Saarma, M. (1992). Brain-derived neurotrophic factor and neuro-
trophin 3 mRNAs in the peripheral target fields of developing inner
ear ganglia. Proc. Natl. Acad. Sci. USA 89, 9915–9919.
Pirvola, U., Spencer-Dene, B., Qing-Qun, L., Kettunen, P., Thesleff,
I., Fritzsch, B., Dickson, C., and Ylikoski, J. (2000). FGF/FGFR-2(IIIb)
signaling is essential for inner ear morphogenesis. J. Neurosci. 20,
6125–6134.
Ruben, R.J. (1967). Development of the inner ear of the mouse: a
radioautographic study of terminal mitoses. Acta Otolaryngol.
Suppl. 220, 1–44.
Tan, S.S., Williams, E.A., and Tam, P.P. (1993). X-chromosome inac-
tivation occurs at different times in different tissues of the post-
implantation mouse embryo. Nat. Genet. 3, 170–174.
Tropepe, V., Sibilia, M., Ciruna, B.G., Rossant, J., Wagner, E.W., and
van der Kooy, D. (1999). Distinct neural stem cells proliferate in
response to EGF and FGF in the developing mouse telencephalon.
Dev. Biol. 208, 166–188.
Tropepe, V., Coles, B.L., Chiasson, B.J., Horsford, D.J., Elia, A.J.,
McInnes, R.R., and van der Kooy, D. (2000). Retinal stem cells in
the adult mammalian eye. Science 287, 2032–2036.
Vaccarino, F.M., Schwartz, M.L., Raballo, R., Nilsen, J., Rhee, J.,
Zhou, M., Doetschman, T., Coffin, J.D., Wyland, J.J., and Hung, Y.T.
(1999). Changes in cerebral cortex size are governed by fibroblast
growth factor during embryogenesis. Nat. Neurosci. 2, 246–253.
Vendrell, V., Carnicero, E., Giraldez, F., Alonso, M.T., and Schim-
mang, T. (2000). Induction of inner ear fate by FGF3. Development
127, 2011–2019.
von Bartheld, C.S., Patterson, S.L., Heuer, J.G., Wheeler, E.F., Both-
well, M., and Rubel, E.W. (1991). Expression of nerve growth factor
(NGF) receptors in the developing inner ear of chick and rat. Devel-
opment 113, 455–470.
Werner, S., Duan, D.S., de Vries, C., Peters, K.G., Johnson, D.E.,
and Williams, L.T. (1992). Differential splicing in the extracellular
region of fibroblast growth factor receptor 1 generates receptor
variants with different ligand-binding specificities. Mol. Cell. Biol.
12, 82–88.
Wilkinson, D.G., and Green, J. (1990). In situ hybridization and the
three-dimensional construction of serial sections. In Postimplanta-
tion Mammalian Embryos, Copp, A.J., and Cockroft, D.L., eds. (New
York: Oxford University Press, IRL), pp. 155–171.
Yamaguchi, T.P., Harpal, K., Henkemeyer, M., and Rossant, J. (1994).
Fgfr-1 is required for embryonic growth and mesodermal patterning
during mouse gastrulation. Genes Dev. 8, 3032–3044.
